Apotex Can't Launch Generic Pulmicort Yet: Judge
A federal court has temporarily blocked Apotex Inc. from launching a generic version of Pulmicort Respules, AstraZeneca Pharmaceuticals LP's successful asthma treatment for children....To view the full article, register now.
Already a subscriber? Click here to view full article